In female breast cancer, HGF/c-MET promotes cell proliferation, migration, and invasion by HGF binding-induced c-MET activation of the phosphoinositide 3-kinase/Akt pathway and the Erk/mitogen-activated protein kinase cascade [14]. This evidence concerns the gene WNK2 and breast carcinoma.